Advertisement

Click here for more guidelines.

 
 




CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2008; 51:1327-1336, doi:10.1016/j.jacc.2007.12.031
© 2008 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (12)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bossé, Y.
Right arrow Articles by Pibarot, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bossé, Y.
Right arrow Articles by Pibarot, P.

CARDIOVASCULAR GENOMIC MEDICINE

Genomics

The Next Step to Elucidate the Etiology of Calcific Aortic Valve Stenosis

Yohan Bossé, PhD*,{dagger},*, Patrick Mathieu, MD{ddagger} and Philippe Pibarot, DVM, PhD, FACC, FAHA§

* Department of Anatomy and Physiology, Laval Hospital Research Center, Laval University, Quebec City, Quebec, Canada
{dagger} Laval University Hospital Research Center (CRCHUL), Quebec City, Quebec, Canada
{ddagger} Department of Surgery, Laval Hospital Research Center/Quebec Heart Institute, Laval University, Quebec City, Quebec, Canada
§ Department of Medicine, Research Group in Valvular Heart Diseases, Laval Hospital Research Center/Quebec Heart Institute, Laval University, Quebec City, Quebec, Canada.

Manuscript received October 23, 2007; revised manuscript received November 27, 2007, accepted December 10, 2007.

* Reprint requests and correspondence: Dr. Yohan Bossé, Laval Hospital Research Centre, Pavillon Margeritte-d’Youville, Y4190, 2725, Chemin Sainte-Foy, Québec City, Québec, Canada G1V 4G5. (Email: yohan.bosse{at}crhl.ulaval.ca).

With the current shift toward an older population, calcific aortic valve stenosis (AVS) is likely to become a major societal and economic burden. For many years, AVS was regarded as a degenerative and nonmodifiable process. However, molecular studies unanimously demonstrated that AVS is an actively regulated disorder with several potential therapeutic targets. Many factors are predicted to cause AVS, and an important genetic predisposition is anticipated. In this review, we describe candidate genes and signaling pathways identified by genetic research and incorporate this new knowledge into a more comprehensive picture of factors involved in the pathogenesis of AVS. We also emphasize the need for additional studies to elucidate its complete genetic architecture. Recent advances in genomic research offer a remarkable opportunity to investigate AVS at the most fundamental level. The benefits of these new approaches can be observed in many complex diseases, but the field of AVS is trailing behind. We discuss the future utility of these new genomic approaches to improve our understanding of AVS and to refine the management of patients in terms of diagnosis, prevention, and treatment.

Abbreviations and Acronyms
  AVS = aortic valve stenosis
  IL = interleukin
  SNP = single nucleotide polymorphism
  TGF = transforming growth factor




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. J. Holliday, R. F. Ankeny, H. Jo, and R. M. Nerem
Discovery of shear- and side-specific mRNAs and miRNAs in human aortic valvular endothelial cells
Am J Physiol Heart Circ Physiol, September 1, 2011; 301(3): H856 - H867.
[Abstract] [Full Text] [PDF]


Home page
Circ Cardiovasc GenetHome page
Y. Bosse, A. Miqdad, D. Fournier, A. Pepin, P. Pibarot, and P. Mathieu
Refining Molecular Pathways Leading to Calcific Aortic Valve Stenosis by Studying Gene Expression Profile of Normal and Calcified Stenotic Human Aortic Valves
Circ Cardiovasc Genet, October 1, 2009; 2(5): 489 - 498.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
C. M. Otto
Calcific aortic valve disease: outflow obstruction is the end stage of a systemic disease process
Eur. Heart J., August 2, 2009; 30(16): 1940 - 1942.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. H. Rahimtoola
The Year in Valvular Heart Disease
J. Am. Coll. Cardiol., May 19, 2009; 53(20): 1894 - 1908.
[Full Text] [PDF]


Home page
CirculationHome page
F. J. Schoen
Evolving Concepts of Cardiac Valve Dynamics: The Continuum of Development, Functional Structure, Pathobiology, and Tissue Engineering
Circulation, October 28, 2008; 118(18): 1864 - 1880.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. N. Bella
Genomics of Aortic Valve Disease
J. Am. Coll. Cardiol., August 5, 2008; 52(6): 498 - 498.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Y. Bosse, P. Mathieu, and P. Pibarot
Reply
J. Am. Coll. Cardiol., August 5, 2008; 52(6): 498 - 499.
[Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement